Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate approves Drug Cost Review Commission after heated debate; measure passes 28–8
Summary
The Rhode Island Senate passed SB 2719 to create a Drug Cost Review Commission after extended debate over scope, funding and whether the measure would shift burdens onto pharmacies rather than controlling manufacturer prices. The bill passed 28–8.
The Rhode Island Senate on Tuesday approved SB 2719, creating a Drug Cost Review Commission charged with reviewing manufacturer pricing for prescription drugs and issuing determinations intended to reduce costs for consumers.
The measure, introduced by Senator DiMario, establishes an advisory committee that includes providers and patients and authorizes the commission to review submissions from manufacturers and sellers to determine whether drug costs are affordable. ‘‘This is a move in the direction of taking a more comprehensive look at making prescription drug costs…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
